We are live on ! Find out more
CBST

CUBIST PHARMACEUTICALS INC
CBST

Delisted

CBST was delisted on the 21st of January, 2015.

Back to rankings

0 hedge funds and large institutions have $0 invested in CUBIST PHARMACEUTICALS INC in 2015 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 302 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 307 → 0 (-307)

100% less funds holding in top 10

Funds holding in top 10: 35 → 0 (-35)

100% less capital invested

Capital invested by funds: $8B → $0 (-$8B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 302

Holders
–
Holders Change
-307
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
-35
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
302
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$625M
2
Vanguard Group
Vanguard Group
Pennsylvania
-$474M
3
BFA
BlackRock Fund Advisors
California
-$309M
4
State Street
State Street
Massachusetts
-$290M
5
HI
HBK Investments
Texas
-$287M
Name Holding Trade Value Shares
Change 		Change in
Stake
D.E. Shaw & Co
51
D.E. Shaw & Co
New York
– -$34M -338,092 Closed
QOP
52
Quinn Opportunity Partners
Virginia
– -$33M -328,000 Closed
GCIA
53
Gabelli & Co Investment Advisers
New York
– -$31.8M -315,987 Closed
CS
54
Credit Suisse
Switzerland
– -$31.3M -311,260 Closed
Hudson Bay Capital Management
55
Hudson Bay Capital Management
Connecticut
– -$30.5M -302,656 Closed
UBS Group
56
UBS Group
Switzerland
– -$29.7M -295,276 Closed
Goldman Sachs
57
Goldman Sachs
New York
– -$28.7M -284,911 Closed
Dimensional Fund Advisors
58
Dimensional Fund Advisors
Texas
– -$27.5M -272,920 Closed
PSAMP
59
P. Schoenfeld Asset Management (PSAM)
New York
– -$27.4M -272,699 Closed
Deutsche Bank
60
Deutsche Bank
Germany
– -$26.7M -265,076 Closed
BPGAM
61
BTG Pactual Global Asset Management
Bermuda
– -$26.4M -262,000 Closed
CPM
62
Chesapeake Partners Management
Maryland
– -$26.3M -260,850 Closed
Bank of America
63
Bank of America
North Carolina
– -$25.9M -256,834 Closed
GI
64
GAMCO Investors
Connecticut
– -$23.8M -236,700 Closed
TCIM
65
TIAA CREF Investment Management
New York
– -$23.6M -234,931 Closed
SAM
66
Sandell Asset Management
New York
– -$23.3M -231,475 Closed
Principal Financial Group
67
Principal Financial Group
Iowa
– -$22.6M -224,530 Closed
PCM
68
Palisade Capital Management
New Jersey
– -$22.4M -222,560 Closed
CI
69
Cowen Inc
New York
– -$21.9M -217,858 Closed
Ameriprise
70
Ameriprise
Minnesota
– -$21.8M -216,307 Closed
Susquehanna International Group
71
Susquehanna International Group
Pennsylvania
– -$21.2M -210,859 Closed
DM
72
Deerfield Management
New York
– -$21.2M -210,200 Closed
BIM
73
BlackRock Investment Management
Delaware
– -$20.8M -206,484 Closed
OAC
74
OMERS Administration Corp
Ontario, Canada
– -$19M -188,500 Closed
VOYA Investment Management
75
VOYA Investment Management
Georgia
– -$18.6M -185,138 Closed
1 2
3
4 5

CBST Hedge Fund Activity: Q1 2015 in Review

0 of the 3,752 institutional investors tracked by Wall St. Rank reported a position in CUBIST PHARMACEUTICALS INC (CBST) for Q1 2015, worth a combined $0 — down 100% from $8B a quarter earlier.

Sellers outnumbered buyers: 302 funds closed out of CBST and 0 opened new positions — a net loss of 302 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Fidelity Investments, exiting entirely with an estimated $625M sold.

  • 0 institutional investors held CUBIST PHARMACEUTICALS INC (CBST) as of Q1 2015, down from 307 in Q4 2014.
  • Funds reported $0 of CUBIST PHARMACEUTICALS INC stock for Q1 2015, down 100% quarter-over-quarter.
  • 0 funds opened new CUBIST PHARMACEUTICALS INC positions in Q1 2015 and 302 closed out, a net change of -302 holders.
  • The largest CUBIST PHARMACEUTICALS INC seller in Q1 2015 was Fidelity Investments, an estimated $625M sold.

Based on aggregated 13F filings for Q1 2015.